For the report, Evaluate Pharma gathered and assessed analysts’ predictions of global drug sales to develop consensus forecasts of the future drug market.
Worldwide pharmaceutical sales are now expected to peak at $1.06 trillion in 2022, compared to $1.12 trillion predicted one year ago, according to the report. The decrease marks the first time in a decade total drug sale predictions failed to surpass the previous year’s forecast.
“The continued political and public scrutiny over pricing of both the industry’s new and old drugs is not going to go away, and we are starting to feel the impact now,” Antonio Iervolino, Evaluate Pharma’s head of forecasting, told Reuters.
More articles on supply chain:
FDA OKs pediatric ADHD drug
Stryker to acquire imaging technology company for $701M
SCOTUS decision reduces drugmakers’ product liability
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.